Topic: Health and Medicine
Dr. Moira Gunn talks about new vaccines for neglected diseases and about a handheld device which can detect disease on the spot with the CEOs from Inviragen and Opko Diagnostics, Dan Stinchcomb and David Steinmiller.
Can monetary incentives get people to lose weight? Yes, at least in the short term, says Harvard business professor Leslie John in this university podcast. John reports on studies using lotteries and the threat of financial loss in getting people to slim their waistlines, an important step in improving health. She spoke at the Stanford Prosocial Briefing.
Dr. Moira Gunn recaps the highlights and talks with the key players from the annual BIO 2012 conference in Boston.
Dr. Moira Gunn talks with experts, Terry Hisey and Matthew Hudes from Deliotte, about the meaning of comparative effectiveness and the term: Bio-Pharma.
Dr. Moira Gunn sits down with Jonathan Koomley, author of Cold Cash, Cool Climate: Science-Based advice for Ecological Entrepreneurs about why he believes the climate problem is misunderstood.
Dr. Moira Gunn talks with Rick Alvarez, Vice President of Operations and Research at Selexys Pharmaceuticals, about his research into Sickle Cell Anemia.
Dr. Moira Gunn learns about the challenge of getting essential medicine to all people while navigating through the legal guarantees of drugs patents, from WTO reps, Keith Rockwell and Antony Taubman.
Dr. Moira Gunn learns about how Organovo has been able to build human blood vessels from CEO, Keith Murphy.
Dr. Moira Gunn talks with Avanir Pharmaceuticals CEO, Keith Katkin about a new treatment for Pseudobulbar Affect which is causes great discomfort for stroke victims.
Dr. Moira Gunn talks about the science behind extremely pre-mature babies with BCO Pharma boss, Seamus O'Loan and then switches gears to discuss pancreatic cancer with Targovax president, Hanne Kristensen.
